miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

Published:2014-07-22 Issue:13 Volume:74 Page:1320-1334
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Corcoran Claire¹,Rani Sweta¹,O'Driscoll Lorraine¹

Affiliation:

1. School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences InstituteTrinity College DublinDublinIreland

Funder

Science Foundation Ireland's funding of Molecular Therapeutics for Cancer, Ireland

EU Co-operation in Science and Technology, ME-HaD

Higher Education Authority's Programme for Research in Third Level Institutions Cycle 5

Trinity Biomedical Sciences Institute

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.22848

Reference64 articles.

1. Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

2. Use and Assessment of PSA in Prostate Cancer

3. Docetaxel-based combination therapy for castration-resistant prostate cancer

4. Management of Advanced Prostate Cancer After First-Line Chemotherapy

5. Role of the MRP1/ABCC1 Multidrug Transporter Protein in Cancer

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers;Non-coding RNA Research;2024-12

2. Extracellular vesicles transport RNA between cells: Unraveling their dual role in diagnostics and therapeutics;Molecular Aspects of Medicine;2024-10

3. Characterizing the role of exosomal miRNAs in metastasis;2024-08-21

4. Exosomal microRNAs: impact on cancer detection, treatment, and monitoring;Clinical and Translational Oncology;2024-07-06

5. Empowering Exosomes with Aptamers for Precision Theranostics;Small Methods;2024-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3